Neumora Therapeutics, Inc.

NMRA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.5B · 96 employees
42
SEC Filings
$1.82
Close 2026-06-01
96
Employees

Business Summary

PART I ITEM 1. B usiness. Overview We are a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by bringing forward the next generation of novel therapies with brain-penetrant chemistry that offer improved treatment outcomes and quality of life for patients. Our therapeutic pipeline currently consists of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. We are advancing a Phase 3 progra...

Latest Stock Quote

NMRA 2026-06-01 $1.82 O:$1.85 H:$1.89 L:$1.78 Vol:0.8M VWAP:$1.8316
origin leaf: b7ecb32850b631831d463fa8f7ce3d00bf2c0be28fdf3d6331c969538d2d8d32

Next Earnings

Q2 FY2026 — expected 2026-08-05

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-130388EDGAR94K words
2025-03-032024-12-310000950170-25-030401EDGAR—
2024-03-072023-12-310000950170-24-027927EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269446EDGAR71K words
2025-08-062025-06-300000950170-25-104138EDGAR—
2025-05-122025-03-310000950170-25-069311EDGAR—
2024-11-122024-09-300000950170-24-125437EDGAR—
2024-08-062024-06-300000950170-24-091737EDGAR—
2024-05-072024-03-310000950170-24-054448EDGAR—
2023-11-012023-09-300000950170-23-057424EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130372EDGAR3K words
2026-02-110001193125-26-045526EDGAR—
2026-01-120001193125-26-009727EDGAR—
2026-01-050001193125-26-001472EDGAR—
2025-11-210001193125-25-291352EDGAR—
2025-11-060001193125-25-268046EDGAR—
2025-10-270001193125-25-250677EDGAR—
2025-10-270001193125-25-250656EDGAR—
2025-08-060000950170-25-103997EDGAR—
2025-05-300001193125-25-132307EDGAR—

42 total filings indexed. 22 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001885522
TickerNMRA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.neumoratx.com
Listed2023-09-15

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7b2ff2b159ced726a38a34171b330cdaea1877959abee6c21f914098ddef4f7f
parent: bb0bdced9ed1df8a11e9e5d8148204d91369ed226a15cd953709632d759446a1
content hash: 8a481e1241c442d516484b33f9c3dc91f3019785daf46b4190b2208027bab323
signed: 2026-06-02T19:02:03.607Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf